Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer

Journal of Urology

Volumn 163, Issue 5, 2000, Pages 1476-1480

  Brawer, Michael K ^a,b,c   Cheli, Carol D ^a,b,c   Neaman, Irene E ^a,b,c   Goldblatt, Joan ^a,b,c   Smith, Carol ^a,b,c   Schwartz, Morton K ^a,b,c   Bruzek, Debra J ^a,b,c   Morris, Deborah L ^a,b,c   Sokoll, Lori J ^a,b,c   Chan, Daniel W ^a,b,c   Yeung, Kwok K ^a,b,c   Partin, Alan W ^a,b,c   Allard, W Jeffrey ^a,b,c  

^a Northwest Prostate Institute   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Prostate; Prostate specific antigen; Prostatic neoplasms; ROC curve

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; PROSTATE SPECIFIC ANTIGEN; PROTEINASE INHIBITOR;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC;

EID: 0034048942     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67646-X     Document Type: Article

References (22)

1. Cancer Facts & Figures - 1998. Atlanta, Georgia: The American Cancer Society. pp. 14-15, 20-24, 1998
2. Oesterling, J. E., Jacobsen, S. J. and Cooner, W. H.: The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. J Urol, 153: 1160, 1995
3. Benson, M. C., Whang, I. S., Pantuck, A. et al: Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol, 147: 815, 1992
4. Djavan, B., Zlotta, A. R., Byttebier, G. et al: Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol, 160: 411, 1998
5. Carter, H. B., Pearson, J. D., Metter, E. J. et al: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA, 267: 2215, 1992
6. Stenman, U-H., Leinonen, J., Alfthan, H. et al: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res, 51: 222, 1991
7. Lilja, H., Christensson, A., Dahlén, U. et al: Prostate-specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem, 37: 1618, 1991
8. Christensson, A., Björk, T., Nilsson, O. et al: Serum prostate specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. J Urol, 150: 100, 1993
9. Catalona, W. J., Partin, A. W., Slawin, K. M. et al: Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA, 279: 1542, 1998
10. Vashi, A. R., Wojno, K. J., Henricks, W. et al: Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system. Urology, 49: 19, 1997
11. Junker, R., Brandt, B., Zechel, C. et al: Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays. Clin Chem, 43: 1588, 1997
12. Nixon, R. G., Meyer, G. E., Blase, A. B. et al: Comparison of 3 investigational assays for the free form of prostate specific antigen. J Urol, 160: 420, 1998
13. Woodrum, D., French, C. and Shamel, L. B.: Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions. Urology, Suppl, 48: 33, 1996
14. Allard, W. J., Zhou, Z. and Yeung, K. K.: Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. Clin Chem, 44: 1216, 1998
15. Brawer, M. K., Meyer, G. E., Letran, J. L. et al: Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology, 52: 372, 1998
16. Morris, D. L., Dillon, P. W., Very, D. L. et al: Bayer Immuno 1 PSA assay: an automated, ultrasensitive method to quantitate total PSA in serum. J Clin Lab Anal, 12: 65, 1998
17. Allard, W. J., Cheli, C. D., Morris, D. L. et al: Multicenter evaluation of the performance and clinical utility in longitudinal monitoring of the Bayer Immuno 1 complexed PSA assay. Int J Biol Markers, 14: 73, 1999
18. Luderer, A. A., Chen, Y. T., Soriano, T. F. et al: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, 46: 187, 1995
19. Catalona, W. J., Smith, D. S., Wolfert, R. L. et al: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA, 274: 1214, 1995
20. España, F., Royo, M., Martínez, M. et al: Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples. J Urol, 160: 2081, 1998
21. Kuriyama, M., Ueno, K., Uno, H. et al: Clinical evaluation of serum prostate-specific antigen-alpha-1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study. Int J Urol, 5: 48, 1998
22. Woodrum, D. L., Brawer, M. K., Partin, A. W. et al: Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J Urol, 159: 5, 1998